R&D channel feed – Endpoints News

R&D channel feed

AACR21: Zentalis keeps the heat on AstraZeneca with early WEE1 data showing a group of 'exceptional' responders

5 years ago

AACR21 roundup: Arcus rolls out PhI data on adenosine blocker for CRC; Codiak's engineered exosome for IL-12 shows early promise

5 years ago

AACR21: Bristol Myers looks to build Opdivo's case in early cancer with full data in pre-surgical NSCLC

5 years ago

AACR21: AstraZeneca unveils next-gen PARP inhibitor, looking to follow up on success of first-gen success story Lynparza

5 years ago

AACR21: Sanofi rolls out new data for early-stage 'non-alpha' IL-2. Early feedback? Interesting, but mostly meh

5 years ago

Laying claim to another AI 'first,' Exscientia tees up an I/O drug for the clinic

5 years ago

AACR: Germany's small NK cell player Affimed makes a big splash with early lymphoma data

5 years ago

Manufacturing briefing: After J&J-Emergent mixup, fewer doses expected in US next week; Boehringer taps Oxford for viral vectors

5 years ago

Bristol Myers' Opdivo notches a double win against chemo in esophageal cancer, potentially setting up 1st-line nod

5 years ago

Looking to rebound from rejection in TNBC, Merck's Keytruda passes a new kidney cancer test

5 years ago

FibroGen shares take a beating as CEO reveals safety data manipulation for its blockbuster contender roxadustat

5 years ago

Takeda, CSL Behring fold big plasma alliance after PhIII flop — joining a slew of antibodies that failed to help hospitalized patients

5 years ago

US government does not own any remdesivir patents, GAO report finds

5 years ago

TCR² plants its flag in former Autolus manufacturing site, planning to add 175 jobs as it advances lead T cell therapy

5 years ago

Looking to prepare for the next flu pandemic, Sanofi drops $700M+ into new Toronto facility for Fluzone production

5 years ago

Wave crashes — again — as 2 more drugs go down to defeat, this time for Huntington's

5 years ago

Ionis unveils positive PhII data for in-house rare disease drug, paving way to blockbuster rivalry with Takeda

5 years ago

Eli Lilly, GlaxoSmithKline-Vir release positive but difficult-to-interpret combo antibody data

5 years ago

Humanigen declares win in severe Covid-19, delivering much-needed pandemic weapon and vaulting ahead on post-Shkreli turnaround

5 years ago

Bristol Myers Squibb, bluebird land once-high-stakes approval on BCMA CAR-T — and it bodes well for rival J&J

5 years ago

Covid-19 roundup: Moderna passes 100M mark for US vaccines in landmark moment; Fake Pfizer vaccine found in Mexico

5 years ago

Orphazyme's pipeline-in-a-product whiffs in second trial, though FDA decision still awaits

5 years ago

Chinese CDMO Raybow quadruples workforce at NC site, hoping to help build next biopharma manufacturing hub

5 years ago

Bristol Myers Squibb outraces the pack to a late-stage trial win for its LAG-3/PD-1 antibody combo in melanoma

5 years ago

First page Previous page 173 174 175176177 178 179 Next page Last page